ACPE Installs New Board Members for 2016-2022 Term of Service
The Accreditation Council for Pharmacy Education (ACPE) has announced the installation of the new ACPE Board of Directors for the 2016 to 2022 term of service. The new board members, who were installed during the ACPE Board of Directors Meeting on June 23-25, 2016, in Chicago, IL, include: Marie A. Chisholm-Burns, MPH, MBA, PharmD, FCCP, […]
Read More ›New Research Shows PDMPs Associated With Reduction in Opioid Overdose Deaths
State prescription drug monitoring programs (PDMPs) were connected to the prevention of nearly one opioid-related overdose death every two hours on average nationwide, reports a new study led by Vanderbilt University. The study, “Implementation of Prescription Drug Monitoring Programs Associated With Reductions in Opioid-Related Death Rates,” analyzed mortality data and data on states’ PDMPs from […]
Read More ›Pharmacists Most Trusted Group in Health Care, According to Survey
Pharmacists were rated as the most trusted health care providers, according to a new consumer health survey. The results of the survey show that 60% of consumers trust pharmacists, 56% trust doctors, and 51% trust dentists. The Meyocks Health Survey reports that consumers trust the people who directly provide health care more than others in […]
Read More ›.Pharmacy TLD Featured in Interview With Neustar
Carmen A. Catizone, MS, RPh, DPh, NABP executive director/secretary, discussed the .pharmacy domain name and its benefits for the domain name industry, registrants, and public health during an interview with Neustar, a company that provides top-level domain (TLD) registry services. Other topics of discussion included the process for registering a .pharmacy domain name, Bing’s revised […]
Read More ›US IP Rights Coordinator Advocates .Pharmacy TLD as Means of Protecting Consumers
During a recent United States Senate Committee hearing, Bruce Foucart, assistant director of the US National Intellectual Property Rights Coordination Center, advocated the .pharmacy Top-Level Domain (TLD) as a means of protecting consumer well-being. The hearing, “Challenges and Opportunities for US Business in the Digital Age,” took place on June 15, 2016, and addressed, in […]
Read More ›NABP Invited to Discuss Best Practices for Restricted TLDs With US Intellectual Property Enforcement Coordinator
The Office of the United States Intellectual Property Enforcement Coordinator held a meeting to discuss the implementation of restricted new generic Top-Level Domains (gTLDs). The objective of the meeting, held on March 15, 2016, was to address the issues impacting restricted gTLDs, such as best practices in operations, consumer awareness, and public policy. Carmen A. […]
Read More ›NABP 112th Annual Meeting to Set Sail in ‘America’s Finest City’ for Important Business Sessions, Timely CPE Programs, and Unique Networking Events
Set in San Diego, CA, a city known for its sunny weather and Pacific coastline views, the National Association of Boards of Pharmacy® (NABP®) 112th Annual Meeting, “All Hands on Deck – Forging Ahead to a New Regulatory World,” will provide attendees an opportunity to explore “America’s Finest City” after participating in important NABP Business […]
Read More ›Summit on Internet Naming System Convenes to Address Best Practices
The first Healthy Domains Initiative summit, hosted by The Domain Name Association, took place this month in Seattle, WA, and provided a forum for discussion about efforts to establish Internet naming system best practices, mitigate online abuse, and define measures for self-regulation. Representatives from registries, registrars, law enforcement agencies, civil society, child protection experts, illegal […]
Read More ›Study Examines Consumer Educational Initiatives Raising Awareness About Internet Drug Outlets, Includes NABP Data
Reviewing the efforts of 13 stakeholder organizations, a new study examines educational programs aimed to raise consumer awareness about the risks of entities that illegally distribute medications online. The study cited NABP’s review of over 10,500 online drug outlets and its finding that 97% of sites visited were not in compliance with applicable pharmacy laws […]
Read More ›Texas Compounding Facility Ordered to Stop Manufacture and Distribution of Products
Downing Labs, LLC, of Dallas, TX, is prohibited from manufacturing, holding, or distributing drugs under a consent decree of permanent injunction entered against the facility by a federal court. The consent decree was sought as a result of a Food and Drug Administration (FDA) inspection of the Downing Labs facility that revealed insanitary conditions and […]
Read More ›